Private equity firm TPG is acquiring a majority stake in health information company Surescripts.
The investment will accelerate Surescripts' ability to scale its existing intelligent prescriptions, benefits and authorizations, and clinical interoperability services, according to an Oct. 1 news release from the company.
The investment will also allow Surescripts to "further streamline the benefits process to reduce clinician burnout, help prescribers more efficiently deliver affordable medications to patients, and support the role of pharmacists as part of an evolving care team," according to the release.
The transaction is subject to customary regulatory approvals. Financial details of the deal were not disclosed.
"We are partnering with TPG because of our shared vision for improving healthcare for patients and the clinicians who care for them," Surescripts CEO Frank Harvey said in the release. "TPG’s support will enable us to scale existing solutions while advancing new innovative technologies that will continue to enhance patient safety, lower costs and ensure quality care, amplifying our impact across healthcare."